logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tao Luo

the first affiliated hospital
H指数:37
被引数:7,116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analysis of the safety and efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy in the treatment of locally advanced resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis based on four randomized controlled trials

PD-1/PD-L1抑制剂联合化疗在局部晚期可切除食管鳞状细胞癌治疗中的安全性与有效性分析：一项基于四项随机对照试验的系统评价与Meta分析

Frontiers in Oncology
IF3.3
2025-08-130
OA
Tao Luo; Hao Yang; Xingqiang Ran; Binwen Xu; Yue Zhang; Liwen Zhang; Chengcheng Zhang; Maoyong Fu
Safety and ef fi cacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial

安洛替尼联合紫杉烷和洛铂在中国临床II/III期三阴性乳腺癌新辅助治疗中的安全性和有效性 (新临床试验): 一项单臂2期试验

ECLINICALMEDICINE
IF10
2024-05-011
OAAI
Liang, Yan; Liu, Jing; Ge, Jia; Shi, Qiyun; Zhang, Guozhi; Wan, Andi; Luo, Tao; Tian, Hao; Fan, Linjun; Wang, Shushu; Chen, Li; Tang, Peng; Zhu, Kai; Jiang, Jun; Bian, Xiuwu; Zhang, Yi; Qi, Xiaowei

研究方向

暂未获取到该数据
Xiuwu Bian 封面图
Xiuwu Bian
H 指数:85论文数:541被引数:2.2万
李霞 封面图
李霞
H 指数:82论文数:1,165被引数:3.3万
王
王红阳
H 指数:96论文数:941被引数:3.5万
B
Bo Su
H 指数:17论文数:41被引数:1,134
S
Shibin Jiang
H 指数:48论文数:285被引数:6,704
肖
肖云
H 指数:46论文数:327被引数:1.4万
Z
Zexuan Yan
H 指数:15论文数:43被引数:824
N
N. Peyghambarian
H 指数:75论文数:1,118被引数:2.2万
Y
Yibin Ren
H 指数:12论文数:28被引数:630
J
Jie Cao
H 指数:44论文数:382被引数:7,828